Molecular Therapy · 2018 · 190 citations · 20 references
MedicineCancer BiologyOncologyGene ExpressionMolecular OncologyNeoplasiaAngiogenesisAngiogenesis In CancerMalignant NeoplasmsMicrorna-mediated RegulationSignal Transduction In CancerTumor BiologyExosomes In CancerMicrorna Function In CancerMicrorna In CancerMicrorna Regulation In CancerMicrorna-mediated OncogenesisScientific Publishing PolicyTargeted Molecular TherapyVascular Endothelial Function
Metastasis is a crucial reason for the poor prognosis of gastric cancer. Angiogenesis is closely associated with tumor invasion and metastasis. Cancer-derived exosomes play an important role in the establishment of the tumor microenvironment. In this study, exosomes were isolated by sequential differential centrifugation, and they were verified by transmission electron microscopy. Changes in the biological behavior of human umbilical vein endothelial cells were evaluated with downstream cellular functional experiments. The RNA and protein levels of the miRNA target gene were determined by real-time qPCR and western blotting. A mouse xenograft model was adopted to evaluate the correlation between exosome-derived miR-130a and tumor growth in vivo. We demonstrated that exosomes delivered miR-130a from gastric cancer cells into vascular cells to promote angiogenesis and tumor growth by targeting c-MYB both in vivo and in vitro. miR-130a packaged in exosomes secreted from cancer cells acts as a driver of angiogenesis. Therefore, miR-130a might be a potential biomarker for monitoring the activity of gastric cancer. In addition, suppressing the expression or blocking the transmission of these exosomes might be a novel antiangiogenic therapeutic strategy for gastric cancer.
20
Glypican-1 identifies cancer exosomes and detects early pancreatic cancer
Sónia A. Melo, Linda B. Luecke, Christoph Kahlert et al. · Nature · 2015 · 2.9K citations · Full text
Claudia Allemani, Hannah K. Weir, Helena Carreira et al. · The Lancet · 2014 · 2.7K citations · Full text
Medicine, Biostatistics, Oncology +17